ARCHIVES

European Commission Approves Subcutaneous Rituximab

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

In Brief: AMA Issues Guidelines For HIV Infection, Smoking Cessation; MDA Appointment

February 4, 1994

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Hammond Resigns As Director Of USC Comp Center

May 29, 1981